The Bancorp Inc (TBBK) Jumps 8.85% on February 10

Equities Staff |

The Bancorp Inc (TBBK) was among the biggest gainers on the Russell 2000 for Wednesday February 10 as the stock popped 8.85% to $4.43, representing a gain of $0.36 per share. Some 122,447 shares traded hands on 1,131 trades, compared with an average daily volume of 184,244 shares out of a total float of 37.76 million. The stock opened at $4.10 and traded with an intraday range of $4.48 to $4.10.

After today's gains, The Bancorp Inc reached a market cap of $167.27 million. The Bancorp Inc has had a trading range between $10.62 and $3.88 over the last year, and it had a 50-day SMA of $5.93 and a 200-day SMA of $7.91.

The stock has a P/E Ratio of 11.

The Bancorp Inc through its holdings provides retail and commercial & private label banking, institutional banking, health savings accounts & prepaid debit cards & prepaid card issuing services.

The Bancorp Inc is based out of Wilmington, DE and has some 684 employees. Its CEO is John C. Chrystal.

For a complete fundamental analysis analysis of The Bancorp Inc, check out’s Stock Valuation Analysis report for TBBK. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Propanc Health Group Corp

Propanc Health Group Corp is an early stage healthcare company. It is engaged in developing new cancer treatments for patients, suffering from pancreatic and colorectal cancer.

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…